SouthViews No. 202, 17 July 2020
Lessons from COVID-19: Pharmaceutical Production as a Strategic Goal
By Dr. Carlos M. Correa
As often said, major crises bring about challenges but also opportunities. The strategic importance of a local pharmaceutical industry has been growingly recognized as a result of the COVID-19 crisis. Developing countries should take advantage of this opportunity to strengthen their pharmaceutical industry, including biological medicines. Industrial policies would need to be reformulated under an integrated approach so as to expand value added & create jobs while addressing public health needs. South-South cooperation may also play an important role in increasing the contribution of developing countries to the global production of pharmaceuticals.
Download the SouthViews:
Lessons from COVID-19: Pharmaceutical Production as a Strategic Goal
This article was tagged: Access to Medicines, Affordable Medicines, Biologics, Biosimilars, Biotechnological Products, Coronavirus, COVID-19, Creative Imitation, Economic Crisis, Employment, European Union (EU), Financial Crisis, Flexibilities, Generic Medicines, Global Health, Global Value Chains (GVCs), Globalization, Government Procurement, Health, Industrial Policy, Innovation, Intellectual Property, Pandemic, Pharmaceuticals, Public Health, Research and Development (R&D), South-South Cooperation, strategic autonomy, Trade, TRIPS, United Nations Conference on Trade and Development (UNCTAD), Vaccines
